ABOUT Dr. Murari Man Shrestha

Preventive Oncology, HOD

Dr. Murari Man Shrestha, MBBS, MD, M.Sc.(Medical Epidemiology) (NMC Regd.351)

Senior Medical Epidemiologist

Special Interest: Medical Epidemiology; Cancer education, prevention, control and Research programs

Dr. Shrestha is one of the senior Medical Epidemiologists working in the field of cancer. He has been contributing in the field of cancer prevention and control at national, regional and local levels for the last fifteen years. At NCHRC, he has been providing technical support in conducting cancer prevention and control activities in the valley and in various districts of Nepal. He is also involved in training and research activities.

He did his Doctor of Medicine (MD) from Crimea Medical Institute, Simferopol, USSR (1985); Master of Science (M.Sc.) in Medical Epidemiology from Mahidol University, Bangkok Thailand (1993); Biostatistics & Epidemiology Course from Johns Hopkins University, Maryland, Baltimore USA (2003). He attended several national and international training courses.

He is the deputy director in cancer prevention committee and member of several working committees including infection prevention and control (IPC), clinical governance and member secretary of hospital research board (HRB) at NCHRC.

As a part of more than 25 years of work experience, he served as medical professional at district and central level hospital and institutions under Government of Nepal/MoHP (1985-1995). He was affiliated with several institutions including BPKM Cancer Hospital (1995-2005), WHO Nepal office and Regional office India in various professional capacities (2005-2013), self employed as Freelance consultant (2013-2017) and NCHRC as a part-time contract till date. He has received many national and international certificates and appreciation for his contribution in the field of medical epidemiology.

He believes that majorities of cancer are preventable and they can be effectively treated if detected in early stage. Education, public awareness and cancer screening programs play a crucial role in early detection and control of cancers.



  1. Genetic analysis of children with congenital ocular anomalies in three ecological regions of Nepal: a phase II of Nepal pediatric ocular diseases study. BMC Med Genet 21, 185 (2020). https://doi.org/10.1186/s12881-020-01116-9.


  1. Caring Cancer Patients While Living With COVID-19: An Experience of a Tertiary Cancer Care Center. An original article.


  1. Post MR Campaign Coverage Survey 2016. Conducted by Center for Molecular Dynamics Nepal (CMDN).


  1. Estimation of the Impact of a Japanese Encephalitis Immunization Program with Live Attenuated SA 14-14-2 Vaccine in Nepal. American Society of Tropical Medicine and Hygiene, January 2013.


  1. Post MR campaign coverage national survey 2012. Government of Nepal, WHO CO, WHO SEARO, WHO HQ and CDC Atlanta.


  1. Effectiveness of single and double freeze cryotherapy techniques in controlling the CIN lesions; a multi-center clinical trial. WHO/IARC, BPKMCH 2003.


  1. Non- Communicable Diseases in Nepal-2000: A pilot survey supported by WHO.


Professional Membership


  1. Life Member, Nepal Medical Association (NMA), Nepal.
  2. Life Member, Society of Public Health Physicians Nepal (SOPHYN).
  3. National Editorial Board Member, Journal of Karnali Academy of Health Sciences, Jumla.